Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 363
Selected: 0
NCT IDTitle
NCT00123929Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
NCT04025229High Intensity Interval Training in Endometrial Cancer
NCT05440929Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
NCT05828927enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers
NCT04274465Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT05620329UNC Pleural Fluid Registry
NCT01751529Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer
NCT01412229Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT03176082Mailed Reminders Plus Fecal Immunochemical Testing
NCT06263582Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
NCT03407430Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain
NCT02564120North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
NCT00233974Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
NCT03077230Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening
NCT04548648A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
NCT03885830Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
NCT04223765Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
NCT06480773Kaposi Sarcoma Chemotherapy and Research (KS-CARE)
NCT00719173Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer
NCT05498220Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT06618274Effectiveness of Central Oncology Navigation and the Use of an ORN
NCT03281720Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases
NCT02075320Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules
NCT02139774Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer
NCT01875666Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
NCT05578326Study of Trilaciclib and Lurbinectidin
NCT01725048Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
NCT00519831Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
NCT04656873Immuno-Oncology Database and Bioregistry
NCT00320073Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT05630131ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05366166Pembrolizumab Plus Olaparib in LA-HNSCC
NCT00448357Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
NCT05978557Brain Slice Explants to Predict Drug Response in Brain Tumors
NCT03602157Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
NCT00610948Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
NCT00405366Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
NCT00776126Digital Breast Tomosynthesis Preference Study
NCT00257426Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
NCT00225420Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
NCT01262820Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab
NCT04073966MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
NCT05743426Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
NCT05592665PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
NCT04743674Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
NCT04092257HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
NCT01488357Patient Preferences for Breast Reconstruction After Mastectomy
NCT00280748Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
NCT03529422Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
NCT03785782ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer